← FDA DRUG APPROVALS

FDA ANDA · ANDA205347

VALSARTAN

Sponsor: SQUARE PHARMS PLC

APPLICATION
ANDA205347
TYPE
ANDA
ORIGINAL APPROVAL
2018-04-09
LATEST ACTION
2019-09-03
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

VALSARTANPrescription
VALSARTAN 40MG · TABLET · ORAL
VALSARTANPrescription
VALSARTAN 320MG · TABLET · ORAL
VALSARTANPrescription
VALSARTAN 80MG · TABLET · ORAL
VALSARTANPrescription
VALSARTAN 160MG · TABLET · ORAL

Approval history

2019-09-03Labeling · Supplement 1 · standardAP
2018-04-09UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →